C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
11/2002
11/12/2002	US6479054 Process for obtaining genistin-rich isoflavone composition
11/12/2002	US6478989 Aromatic substituted naphthopyrans
11/11/2002	CA2385510A1 Use of hydroxyflavanones for masking bitter taste
11/07/2002	WO2002089128A1 An optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
11/07/2002	WO2002088117A2 Method for producing 2-[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane
11/07/2002	WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	US20020165268 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165169 Therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	US20020164498 Novel compound for red organic electroluminescent elements and devices
11/07/2002	CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/06/2002	EP1254955A1 A method for regulating gene expression
11/06/2002	EP1254884A2 Preparation of vinyl ethers from alcohols and alkenes
11/06/2002	EP1254132A1 Food product and process
11/06/2002	EP1254131A1 Extraction of flavonoids
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1253909A2 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias
11/06/2002	EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002	CN1378558A Processes for producing and purifying aspartame derivatives and process for producing intemediates
11/05/2002	US6476241 Synthesis of 4α-arylepicatechins
11/05/2002	US6476011 Methods for introducing an estrogenic compound
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086879A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound
10/31/2002	WO2002086878A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers
10/31/2002	WO2002085891A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
10/31/2002	WO2002085882A1 Coumarin derivatives to be used as anticoagulants
10/31/2002	WO2002085881A1 Process for the preparation of isoflavones
10/31/2002	WO2002085880A1 Process for producing nitrile compound
10/31/2002	WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002	US20020161247 Process for making vitamin E using hydrogen-tris(oxalato) phosphate
10/31/2002	US20020161246 Converting trimethylhydroquinone diacetate (TMHQ-DA) into the corresponding monoacetate (TMHQ-1-MA) with a lipase
10/31/2002	US20020161245 From salicylaldehyde derivatives and alkyl cyanoacetates and using a molecular sieve; chromene derivatives that bind to Bcl-2 protein and induce apoptosis in tumor cells
10/31/2002	US20020161036 Chalcone coumarins
10/31/2002	US20020161035 Medicaments for chemotherapeutic treatment of disease
10/31/2002	US20020160983 Substituted benzopyranones as telomerase inhibitors
10/31/2002	US20020160965 Cosmetic and dermatological formulations comprising flavonoids
10/31/2002	US20020160303 Unsaturated ether containing polymer
10/31/2002	DE10120619A1 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman 2- (5- (4-fluorophenyl) -3-pyridylmethylaminomethyl-chromane
10/31/2002	CA2445160A1 Coumarin derivatives to be used as anticoagulants
10/30/2002	EP1252137A1 Palatable arginine compounds and uses thereof for cardiovascular health
10/30/2002	EP1159254A4 Oxyalkylene-substituted aminophenol intermediate
10/30/2002	EP0960109B1 Process to prepare tolterodine
10/30/2002	CN1093540C Method for extracting nicotine and melim from low quality tobacco leaves
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002	US6471973 Drugs, cosmetics, dietetics, agriculture
10/29/2002	CA2210492C Neuraminic acid derivatives, their preparation and their medical use
10/24/2002	WO2002084656A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g
10/24/2002	WO2002070506A3 Conversion of cbd to δ8-thc and δ9-thc
10/24/2002	WO2002066428A3 Non-steroidal estrogen receptor ligands
10/24/2002	WO2002055522A3 Novel multi-ring organic compounds for regulating gut motility and food intake
10/24/2002	US20020156090 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
10/24/2002	US20020156077 Antiproliferative agents against estrogen-dependent cancer cells dibenzothiopyran, dibenzopyran and phenanthrene derivatives
10/24/2002	US20020156054 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/24/2002	US20020156024 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/24/2002	US20020155606 Method for regulating gene expression
10/24/2002	US20020155381 Multilayer; radiation transparent substrate, reflection layers, protective coatings
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1003458B1 Liver function test
10/23/2002	EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1375499A Method of extracting and separating several components from mangsteen
10/23/2002	CN1375492A Method of extracting soybean isoflavone
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CA2382994A1 A method for regulating gene expression
10/22/2002	US6469109 Copper clad laminates
10/22/2002	US6469053 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
10/22/2002	US6469051 Diaminorhodamine derivative
10/22/2002	US6469031 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/22/2002	US6469028 Synthesis and use of retinoid compounds having negative hormone and/or anatgonist activities
10/17/2002	WO2002081491A2 New genistein derivatives and pharmaceutical preparations containing them
10/17/2002	WO2002081462A1 Aminoflavone compounds, compositions, and methods of use thereof
10/17/2002	WO2002080912A1 Reconstitutable parenteral composition containing a cox-2 inhibitor
10/17/2002	WO2002080904A1 Liver funcion protecting or ameliorating agent
10/17/2002	WO2002080903A1 Functional role for cannabinoids in autonomic stability during sleep
10/17/2002	WO2002050081A3 Antimicrobial agents
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151582 Inhibiting proteasomal chymotrypsin-like activity
10/17/2002	US20020151560 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248778A1 Substituted photochromic 2h-naphtho 1,2-b] pyran compounds
10/16/2002	EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002	CN1374957A Benzopyran derivative
10/16/2002	CN1374303A Production process of water soluble ginkgo leaf extractive
10/16/2002	CN1374302A Extracting process of eliminating ginkgolic acid from ginkgo leaf extractive
10/16/2002	CN1374301A Process of eliminating tannic acid from ginkgo leaf extractive
10/16/2002	CN1374300A Resin process of eliminating ginkgolic acid from gingko leaf extractive
10/16/2002	CN1092650C Process for producing isochroman compounds
10/15/2002	US6465663 Ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-naphthalen-8(7h)-one-2 -yl)ethenyl)benzoate and ethyl (e)-4-(2-(5,6-dihydro-5,5-dimethyl-8-(phenylthio)-naphthalenyl)ethenyl) benzoate
10/15/2002	US6465457 Carbonate, carbamate, thiocarbonate dithiocarbonate and thiocarbomate derivatives useful as fungicides
10/15/2002	US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
10/10/2002	WO2002080164A1 Optical recording medium
10/10/2002	WO2002080163A1 Optical data carrier containing a cyclizable compound in the information layer
10/10/2002	WO2002080162A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light
10/10/2002	WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080152A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer

1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 242